Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken

Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...

Descripción completa

Detalles Bibliográficos
Autores principales: Matoo, Javaid Jeelani, Bashir, Khalid, Kumar, Ajay, Krishnaswamy, Narayanan, Dey, Sohini, Chellappa, Madhan Mohan, Ramakrishnan, Saravanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127065/
https://www.ncbi.nlm.nih.gov/pubmed/29635053
http://dx.doi.org/10.1016/j.micpath.2018.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127065/
https://www.ncbi.nlm.nih.gov/pubmed/29635053
http://dx.doi.org/10.1016/j.micpath.2018.04.012

Ejemplares similares